CD44 and breast cancer: In terms of breast cancer, when CD44 was knocked down in a CD44+/CD24− breast cancer cell subpopulation, BCSCs differentiated into non-BCSCs with low tumor potential and altered the cell cycle and expression profiles of some stem cell-related genes (7).